These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 9244221)
1. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Anker SD; Chua TP; Ponikowski P; Harrington D; Swan JW; Kox WJ; Poole-Wilson PA; Coats AJ Circulation; 1997 Jul; 96(2):526-34. PubMed ID: 9244221 [TBL] [Abstract][Full Text] [Related]
2. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Anker SD; Coats AJ Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500 [TBL] [Abstract][Full Text] [Related]
3. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Nagaya N; Uematsu M; Kojima M; Date Y; Nakazato M; Okumura H; Hosoda H; Shimizu W; Yamagishi M; Oya H; Koh H; Yutani C; Kangawa K Circulation; 2001 Oct; 104(17):2034-8. PubMed ID: 11673342 [TBL] [Abstract][Full Text] [Related]
4. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Anker SD; Rauchhaus M Curr Opin Cardiol; 1999 May; 14(3):211-6. PubMed ID: 10358792 [TBL] [Abstract][Full Text] [Related]
5. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Ponikowski P; Piepoli M; Chua TP; Banasiak W; Francis D; Anker SD; Coats AJ Eur Heart J; 1999 Nov; 20(22):1667-75. PubMed ID: 10543930 [TBL] [Abstract][Full Text] [Related]
6. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. Hryniewicz K; Androne AS; Hudaihed A; Katz SD J Card Fail; 2003 Dec; 9(6):464-8. PubMed ID: 14966787 [TBL] [Abstract][Full Text] [Related]
7. The syndrome of cardiac cachexia. Anker SD; Sharma R Int J Cardiol; 2002 Sep; 85(1):51-66. PubMed ID: 12163209 [TBL] [Abstract][Full Text] [Related]
8. [Chronic heart failure and cachexia: role of endocrine system]. Dei Cas A; Muoio A; Zavaroni I Minerva Cardioangiol; 2011 Dec; 59(6):601-12. PubMed ID: 19946251 [TBL] [Abstract][Full Text] [Related]
9. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897 [TBL] [Abstract][Full Text] [Related]
10. Chronic heart failure and cardiac cachexia and links between the endocrine and immune systems. Anker SD; Cicoira M Z Kardiol; 1999 Oct; 88(Suppl 3):S018-23. PubMed ID: 27320305 [TBL] [Abstract][Full Text] [Related]
11. Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure. Agapitou V; Dimopoulos S; Kapelios C; Karatzanos E; Manetos C; Georgantas A; Ntalianis A; Terrovitis J; Karga H; Nanas S J Heart Lung Transplant; 2013 Apr; 32(4):431-6. PubMed ID: 23402947 [TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298 [TBL] [Abstract][Full Text] [Related]
13. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. Niebauer J; Pflaum CD; Clark AL; Strasburger CJ; Hooper J; Poole-Wilson PA; Coats AJ; Anker SD J Am Coll Cardiol; 1998 Aug; 32(2):393-7. PubMed ID: 9708466 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study. Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097 [TBL] [Abstract][Full Text] [Related]
15. Cardiac cachexia. Anker SD; Steinborn W; Strassburg S Ann Med; 2004; 36(7):518-29. PubMed ID: 15513302 [TBL] [Abstract][Full Text] [Related]
16. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Anker SD; Swan JW; Volterrani M; Chua TP; Clark AL; Poole-Wilson PA; Coats AJ Eur Heart J; 1997 Feb; 18(2):259-69. PubMed ID: 9043843 [TBL] [Abstract][Full Text] [Related]